Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.

about

Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.

Item

http://www.wikidata.org/entity/Q37417622

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Immunological quality and perf ...... mRNA-EP for clinical research.

@en

Immunological quality and perf ...... mRNA-EP for clinical research.

@nl

type

Item

label

Immunological quality and perf ...... mRNA-EP for clinical research.

@en

Immunological quality and perf ...... mRNA-EP for clinical research.

@nl

prefLabel

Immunological quality and perf ...... mRNA-EP for clinical research.

@en

Immunological quality and perf ...... mRNA-EP for clinical research.

@nl

P1476

Immunological quality and perf ...... mRNA-EP for clinical research.

@en

P2093

Kanako Inoo

http://www.w3.org/2001/XMLSchema#string

Kento Fujiwara

http://www.w3.org/2001/XMLSchema#string

Naoki Okada

http://www.w3.org/2001/XMLSchema#string

Ryo Inagaki

http://www.w3.org/2001/XMLSchema#string

Shigemi Sasawatari

http://www.w3.org/2001/XMLSchema#string

Shinsaku Nakagawa

http://www.w3.org/2001/XMLSchema#string

Takashi Kamigaki

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

CAR T cells for solid tumors: armed and ready to go?

Genetically modified T cells for the treatment of malignant disease

Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells

Designing chimeric antigen receptors to effectively and safely target tumors

Adoptive immunotherapy for cancer: harnessing the T cell response

The tumor microenvironment and strategies to improve drug distribution

P304

16024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTO.2016.24

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27909701

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

5111575

http://www.w3.org/2001/XMLSchema#string